Multiscale Multiparametric MRI Deep Learning for Short‐Term Survival Assessment in Glioblastoma
Journal of Magnetic Resonance Imaging · 2026-12 · 64 (6) · 1662-1676
DOI: 10.1002/jmri.70497 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 15.08.2026. Verfasst von Hongbo Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Image Center, Shenzhen Hospital, Southern Medical University (Shenzhen School of Clinical Medicine, Southern Medical University), Shenzhen, G…. Hauptthemen laut MEDLINE: Glioblastoma, Deep Learning, Brain Neoplasms, Multiparametric Magnetic Resonance Imaging. Die Arbeit nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Natural Science Foundation of Shenzhen Municipality.
Abstract (Originalsprache)
Background
Preoperative identification of short‐term survival in glioblastoma may guide management but remains challenging because of clinical and imaging heterogeneity.
Purpose
To develop and externally validate a multiscale magnetic resonance imaging (MRI)‐based deep learning model for short‐term survival assessment and explore transcriptomic correlates. Study Type Retrospective, multicenter. Population Adults with pathologically confirmed, newly diagnosed glioblastoma ( n = 728): training cohort ( n = 290; median age, 55 years; 169 men) and external cohorts 1–3 ( n = 225/182/31; median ages, 64/61/56 years; 136/108/20 men, respectively). Field Strength/Sequence 1.5 T or 3.0 T; axial precontrast T1‐weighted, T2‐weighted, T2‐weighted fluid‐attenuated inversion recovery, and postcontrast T1‐weighted MRI. Assessment Short‐term survival was overall survival of 9 months or less. Whole‐brain, three‐dimensional tumor, and 2.5‐dimensional tumor inputs were integrated and compared with clinical, conventional MRI morphometric, and combined clinical‐MRI baselines. Statistical Tests Kruskal–Wallis, Mann–Whitney U /Wilcoxon rank‐sum, chi‐square, Fisher exact, DeLong, and log‐rank tests; Benjamini–Hochberg false discovery rate (FDR) correction; calibration, decision curves, edgeR, and correlation‐adjusted mean‐rank gene‐set testing were used. Areas under the receiver operating characteristic curve (AUCs) with 95% confidence intervals (CIs) summarized discrimination; threshold metrics used the Youden index. Two‐sided p < 0.05 or FDR‐adjusted p < 0.05 indicated significance.
Results
Apparent training AUC was 0.870 (95% CI: 0.830, 0.910); external AUCs were 0.871 (95% CI: 0.821, 0.920), 0.828 (95% CI: 0.761, 0.895), and 0.798 (95% CI: 0.640, 0.956). AUC gains over the combined clinical‐MRI morphometric baseline were 0.161 and 0.131 in external cohorts 1 and 2; only cohort 1 remained significant after FDR correction (cohort 2, FDR‐adjusted p = 0.0897). Immune/inflammatory and cell‐division/genome‐maintenance pathway associations were directionally concordant, significant after FDR correction in both cohorts, and leave‐one‐out consistent. Data Conclusion Multiscale MRI deep learning demonstrated favorable discrimination for short‐term survival; model output was associated with immune‐ and cell‐cycle‐related transcriptomic programs. Evidence Level 3. Technical Efficacy Stage 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Image Center, Shenzhen Hospital, Southern Medical University (Shenzhen School of Clinical Medicine, Southern Medical University), Shenzhen, Guangdong, China.
- Shenzhen School of Clinical Medicine, Southern Medical University (Shenzhen Hospital, Southern Medical University), Shenzhen, Guangdong, China.
- Department of Radiology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China.
- Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Beibei Zhou, Hanwen Zhang, Yubao Liu
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Natural Science Foundation of Shenzhen Municipality
Zitieren
APA
Zhang, H., Zhou, B., Zhao, X., Jing, S., Zhang, H., Huang, B., Yang, Z., Wang, J., & Liu, Y. (2026). Multiscale Multiparametric MRI Deep Learning for Short‐Term Survival Assessment in Glioblastoma. Journal of Magnetic Resonance Imaging, 64(6), 1662-1676. https://doi.org/10.1002/jmri.70497
Vancouver
Zhang H, Zhou B, Zhao X, Jing S, Zhang H, Huang B, et al. Multiscale Multiparametric MRI Deep Learning for Short‐Term Survival Assessment in Glioblastoma. Journal of Magnetic Resonance Imaging. 2026;64(6):1662-1676. doi:10.1002/jmri.70497
BibTeX
@article{Zhang2026,
author = {Zhang, Hongbo and Zhou, Beibei and Zhao, Xinzhu and Jing, Siqing and Zhang, Hanwen and Huang, Biao and Yang, Zhongxian and Wang, Jinhua and Liu, Yubao},
title = {Multiscale Multiparametric MRI Deep Learning for Short‐Term Survival Assessment in Glioblastoma},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
volume = {64},
number = {6},
pages = {1662--1676},
doi = {10.1002/jmri.70497}
}
EUVIMED